CARDIOTOXICIDAD POR QUIMIOTERAPIA PDF

Download Citation on ResearchGate | On Dec 1, , Edwin Arévalo Guerrero and others published Rol del strain miocárdico en. Abstract. RUIZ-MORI, Enrique; AYALA-BUSTAMANTE, Leonor; BURGOS- BUSTAMANTE, Jorge and PACHECO ROMAN, Cristian. Chemotherapy-induced . Resumen. RUIZ-MORI, Enrique; AYALA-BUSTAMANTE, Leonor; BURGOS- BUSTAMANTE, Jorge y PACHECO ROMAN, Cristian. Chemotherapy-induced.

Author: Voodooll Fenrijinn
Country: Myanmar
Language: English (Spanish)
Genre: Spiritual
Published (Last): 11 October 2009
Pages: 346
PDF File Size: 15.6 Mb
ePub File Size: 15.80 Mb
ISBN: 632-8-68349-378-2
Downloads: 12854
Price: Free* [*Free Regsitration Required]
Uploader: Shaktimi

Thalidomide and dexamethasone for resistant multiple myeloma. Brana I, Tabernero J.

Cardiotoxicidad inducida por quimioterapia

ErbB2 is essential crdiotoxicidad the prevention of dilated cardiomyopathy. Aspectos fundamentais que devem ser considerados no manejo desses pacientes: Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer.

Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.

Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Lapatinib and breast cancer: Chin Med J Engl.

Cardiotoxicidwd use is associated with improved prostate cancer survival: Apresentam atividade antitumoral significativa contra o carcinoma do colo uterino, linfomas e tumores testiculares 4. Carvedilol inhibits clinical progression in patients with mild symptoms of quimioferapia failure. Doxorubicin and paclitaxel in advanced breast carcinoma: Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity.

  GURPS SPACESHIPS PDF

J Gen Intern Med. Torsade de pointes associated with hypokalemia after anthracycline treatment in a patient with acute lymphocytic leukemia.

Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: Early diagnosis of chemotherapy-induced cardiomyopathy: Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.

Clin Adv Hematol Oncol.

[Anthracycline-induced cardiotoxicity: report of fatal cases].

Subacute coronary stent thrombosis in cancer patients. Type II chemotherapy-related cardiac dysfunction: Cardiotoxicity induced by chemotherapy and antibody therapy.

Ewertz M, Jensen AB. However, users may print, download, or email articles for individual use. Nevertheless, this has been obscured by the toxicity of these therapies.

Chemotherapy is indicated in several phases of the antineoplastic treatment, either as neoadjuvant, adjuvant or palliative therapy.

Cxrdiotoxicidad and outcomes of patients with cancer requiring admission to intensive care units: Entretanto, casos de torsades de pointes foram descritos em pacientes com hipocalemia ou hipomagnesemia Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Cardiac dysfunction induced by novel targeted anticancer therapy: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. Guidelines for cardiac monitoring of children during and after anthracycline therapy: Prasugrel as a potential cancer promoter: Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: Clinical practice guidelines in oncology.

  EL OFICIO DE VIVIR DE CESARE PAVESE PDF

quimiotegapia

Int J Immunopathol Pharmacol. Carvedilol Heart Failure Study Group. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. How to cite this article. The objective of this article is to review the state of the art of the chemotherapy-induced cardiotoxicity, as well as to synthesize the different cardiotoxic effects, cardiotoxic mechanisms and methods that have been developed for its diagnosis and prevention.

Thalidomide therapy and deep venous thrombosis in multiple myeloma. The clinical impact of a cardiologic follow-up in breast cancer survivors: Early and late arrhythmogenic effects of doxorubicin. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. Initial assessment, surveillance, and dardiotoxicidad of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors.